Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 8/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3679584 | 0.83 | CA1 (0.48) | CA1CA2PTGS1PTGS2ALOX5 | |
| SCHEMBL4851060 | 0.83 | TUBB1 (0.32) | LMNACYP3A4 | |
| SCHEMBL4088743 | 0.77 | ALDH1A1 (0.38) | CA1CA2ALDH1A1ACHEMAPT | |
| SCHEMBL4578633 | 0.76 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL28234038 | 0.76 | TP53 (0.46) | ESR1ESR2ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL4086875 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CYP2C9ACHEMAPTCYP3A4 | |
| SCHEMBL4859496 | 0.74 | TDP1 (0.46) | ALDH1A1LMNAMAPTMEN1KMT2A | |
| SCHEMBL580906 | 0.74 | CA1 (0.55) | CA1CA2PTGS1PTGS2ALOX5 | |
| Ammonia Solution, Strong SCHEMBL29088797 | 0.73 | ALDH1A1 (0.39) | ALDH1A1CYP2C9ACHEMAPTCYP3A4 | |
| SCHEMBL27831721 | 0.73 | ALDH1A1 (0.39) | ALDH1A1CYP2C9ACHEMAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863919-B1 | SUPPORTED CATALYST CONTAINING TETHERED CATION FORMING ACTIVATOR | DOW CHEMICAL CO (US) | 2000-11-15 | — | — | EP | claimed |
| US-7722784-B2 | Liquid crystal composition, liquid crystal device, reflection display material, light modulating material, and anthraquinone compound | FUJIFILM CORPORATION (JP) | 2010-05-25 | — | — | US | disclosed |
| US-20090074991-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DEVICE, REFLECTION DISPLAY MATERIAL, LIGHT MODULATING MATERIAL, AND ANTHRAQUINONE COMPOUND | FUJIFILM CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| EP-1123321-B1 | SUPPORTED BIDENTATE AND TRIDENTATE CATALYST COMPOSITIONS AND OLEFIN POLYMERIZATION USING SAME | GRACE W R & CO (US) | 2006-12-20 | — | — | EP | disclosed |
| CN-1146583-C | Supported bidentate and tridentate catalyst compositions and olefin polymerization using same | — | 2004-04-21 | — | — | CN | disclosed |
| CN-1328576-A | Supported bidentate and tridentate catalyst compositions and olefin polymerization using same | GRACE W R & CO (US) | 2001-12-26 | — | — | CN | disclosed |
| EP-1123321-A1 | SUPPORTED BIDENTATE AND TRIDENTATE CATALYST COMPOSITIONS AND OLEFIN POLYMERIZATION USING SAME | W.R. Grace & Co.-Conn. (US) | 2001-08-16 | — | — | EP | disclosed |
| WO-2000020467-A1 | SUPPORTED BIDENTATE AND TRIDENTATE CATALYST COMPOSITIONS AND OLEFIN POLYMERIZATION USING SAME | W.R. GRACE & CO.-CONN (US) | 2000-04-13 | — | — | WO | disclosed |
| CN-1202909-A | Supported catalyst containing tetherod cation forming activator | DOW CHEMICAL CO (US) | 1998-12-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074991-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DEVICE, REFLECTION DISPLAY MATERIAL, LIGHT MODULATING MATERIAL, AND ANTHRAQUINONE COMPOUND | CXCR1, CRY1, NLRP1 | CA1 1360/4885CA2 2867/4885PTGS1 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.